Garrone O - Search Results

1

Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial.

Guarneri V, Giorgi CA, Cinieri S, Bengala C, Mariani G, Bisagni G, Frassoldati A, Zamagni C, De Rossi C, Amoroso V, Andreetta C, Ferro A, Zambelli A, Gori S, Garrone O, Dieci MV, Orlando L, Pastina I, Beninato T, Moretti G, Genovesi E, Cinefra M, Vicini R, Magni G, De Salvo GL, Conte P. Guarneri V, et al. Among authors: garrone o. Eur J Cancer. 2021 Sep;154:21-29. doi: 10.1016/j.ejca.2021.05.008. Epub 2021 Jul 2. Eur J Cancer. 2021. PMID: 34225066 Free article. Clinical Trial.

2

Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience.

Denaro N, Garrone O, Ghidini M, Tomasello G, Hahne JC, Merlano MC, Locati LD. Denaro N, et al. Among authors: garrone o. J Clin Med. 2022 Dec 9;11(24):7312. doi: 10.3390/jcm11247312. J Clin Med. 2022. PMID: 36555928 Free PMC article.

3

[Feasibility of a cyclophosphamide methotrexate and 5-fluorouracil regime intravenously administered with and without granulocyte-colony stimulating factor in surgically treated breast carcinoma].

Garrone O, Del Mastro L, Mariani GL, Ardizzoni A, Venturini M, Rosso R. Garrone O, et al. Minerva Med. 1993 Sep;84(9):467-72. Minerva Med. 1993. PMID: 7504219 Italian.

4

A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer.

Del Mastro L, Garrone O, Sertoli MR, Canavese G, Catturich A, Guenzi M, Rosso R, Venturini M. Del Mastro L, et al. Among authors: garrone o. Eur J Cancer. 1994;30A(5):606-10. doi: 10.1016/0959-8049(94)90529-0. Eur J Cancer. 1994. PMID: 7521652 Clinical Trial.

5

Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy.

Venturini M, Del Mastro L, Melioli G, Balleari E, Garrone O, Pasquetti W, Bason C, Ghio R, Bruzzi P, Rosso R. Venturini M, et al. Among authors: garrone o. Cancer. 1994 Oct 15;74(8):2300-6. doi: 10.1002/1097-0142(19941015)74:8<2300::aid-cncr2820740814>3.0.co;2-k. Cancer. 1994. PMID: 7522948

6

High dose intensity chemotherapy without bone marrow support: role of granulocyte-macrophage colony-stimulating factor.

Venturini M, Del Mastro L, Ardizzoni A, Sertoli MR, Mariani GL, Pennucci MC, Garrone O, Silvestro S, Addamo GF, Queirolo P, et al. Venturini M, et al. Among authors: garrone o. Ann N Y Acad Sci. 1993 Nov 30;698:389-97. doi: 10.1111/j.1749-6632.1993.tb17231.x. Ann N Y Acad Sci. 1993. PMID: 8279779 Review. No abstract available.

7

High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer.

Ardizzoni A, Venturini M, Crinò L, Sertoli MR, Bruzzi P, Pennucci MC, Mariani GL, Garrone O, Bracarda S, Rosso R, et al. Ardizzoni A, et al. Among authors: garrone o. Eur J Cancer. 1993;29A(5):687-92. doi: 10.1016/s0959-8049(05)80347-8. Eur J Cancer. 1993. PMID: 8385970

8

Single-agent pegylated liposomal doxorubicin (Caelix) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial.

Numico G, Castiglione F, Granetto C, Garrone O, Mariani G, Costanzo GD, Ciura PL, Gasco M, Ostellino O, Porcile G, Merlano M. Numico G, et al. Among authors: garrone o. Lung Cancer. 2002 Jan;35(1):59-64. doi: 10.1016/s0169-5002(01)00269-0. Lung Cancer. 2002. PMID: 11750714 Clinical Trial.

9

Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.

Venturini M, Durando A, Garrone O, Colozza MA, Contu A, Stevani I, Genta F, Bighin C, Lambiase A, Del Mastro L. Venturini M, et al. Among authors: garrone o. Cancer. 2003 Mar 1;97(5):1174-80. doi: 10.1002/cncr.11203. Cancer. 2003. PMID: 12599222 Free article. Clinical Trial.

10

Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine.

Numico G, Garrone O, Dongiovanni V, Silvestris N, Colantonio I, Di Costanzo G, Granetto C, Occelli M, Fea E, Heouaine A, Gasco M, Merlano M. Numico G, et al. Among authors: garrone o. Cancer. 2005 Mar 1;103(5):994-9. doi: 10.1002/cncr.20893. Cancer. 2005. PMID: 15666321 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page